Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice

Soluble Epoxide Hydrolase Inhibitor Attenuates Inflammation and Airway Hyperresponsiveness in Mice

(2015) Jun Yang et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

14,15-Epoxyeicosatrienoic Acid Suppresses Cigarette Smoke Extract-Induced Apoptosis in Lung Epithelial Cells by Inhibiting Endoplasmic Reticulum Stress

(2015) Ganggang Yu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

CYP2J2 and EETs Protect Against Lung Ischemia/Reperfusion Injury via Anti-Inflammatory Effects in Vivo and in Vitro

(2015) Wenshu Chen et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions

(2015) Veronica Della Latta et al.   PHARMACOLOGICAL RESEARCH

Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models

(2013) Jun-Yan Liu et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Aging, Estrogen Loss and Epoxyeicosatrienoic Acids (EETs)

(2013) Alison R. Lee et al.   PLoS One

Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis

(2013) P. Sirish et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Real world experiences: Pirfenidone is well tolerated in patients with idiopathic pulmonary fibrosis

(2013) Nazia Chaudhuri et al.   RESPIRATORY MEDICINE

Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice

(2013) Wei Liu et al.   RESPIRATORY RESEARCH

Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys

(2012) A Ulu et al.   BRITISH JOURNAL OF PHARMACOLOGY

Delivery of AAV2-CYP2J2 Protects Remnant Kidney in the 5/6-Nephrectomized Rat via Inhibition of Apoptosis and Fibrosis

(2012) Gang Zhao et al.   HUMAN GENE THERAPY

Epoxyeicosatrienoic acids are involved in the C70 fullerene derivative–induced control of allergic asthma

(2012) Sarah K. Norton et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases

(2011) Xizhen Xu et al.   ADVANCED DRUG DELIVERY REVIEWS

Improved bioavailability of epoxyeicosatrienoic acids reduces TP-receptor agonist-induced tension in human bronchi

(2011) Farid Yannick Senouvo et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Integrating mechanisms of pulmonary fibrosis

(2011) Thomas A. Wynn   JOURNAL OF EXPERIMENTAL MEDICINE

Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice

(2011) Guangzhi Chen et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Cytochrome P450-Derived Epoxyeicosatrienoic Acids and Pulmonary Hypertension: Central Role of Transient Receptor Potential C6 Channels

(2010) Annemarieke E Loot et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Quantitative Profiling Method for Oxylipin Metabolome by Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry

(2009) Jun Yang et al.   ANALYTICAL CHEMISTRY

Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge

(2009) L. Kiss et al.   EUROPEAN RESPIRATORY JOURNAL

Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats

(2009) Marc Revermann et al.   JOURNAL OF HYPERTENSION